Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine sustained-release microspheres for post-hemorrhoidectomy analgesia
CTR20233870Phase 2Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Dec 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ropivacaine in postoperative pain, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Dec 2023; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20233870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233870.